Early postnatal defects in neurogenesis in the 3xTg mouse model of Alzheimer's disease

Alzheimer's disease (AD) is a progressive neurodegenerative disorder leading to dementia. The hippocampus, which is one of the sites where neural stem cells reside and new neurons are born, exhibits the most significant neuronal loss in AD. A decline in adult neurogenesis has been described in several animal models of AD. However, the age at which this defect first appears remains unknown. To determine at which stage, from birth to adulthood, the neurogenic deficits are found in AD, we used the triple transgenic mouse model of AD (3xTg). We show that defects in neurogenesis are present as early as postnatal stages, well before the onset of any neuropathology or behavioral deficits. We also show that 3xTg mice have significantly fewer neural stem/progenitor cells, with reduced proliferation and decreased numbers of newborn neurons at postnatal stages, consistent with reduced volumes of hippocampal structures. To determine whether there are early changes in the molecular signatures of neural stem/progenitor cells, we perform bulk RNA-seq on cells sorted directly from the hippocampus. We show significant changes in the gene expression profiles at one month of age, including genes of the Notch and Wnt pathways. These findings reveal impairments in neurogenesis very early in the 3xTg AD model, which provides new opportunities for early diagnosis and therapeutic interventions to prevent neurodegeneration in AD.

Automated summary

Alzheimer's disease (AD) is a progressive neurodegenerative disorder leading to dementia. The hippocampus, one of the main sites for neurogenesis, exhibits significant neuronal loss in AD. Using the 3xTg mouse model, researchers discovered that neurogenic deficits are present during postnatal stages, even before the onset of neuropathology or behavioral deficits. Specifically, the 3xTg mice had fewer neural stem/progenitor cells, reduced proliferation, and decreased numbers of newborn neurons. The findings suggest that impairments in neurogenesis occur early in AD, opening up possibilities for early diagnosis and intervention.